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Abstract 
Lipodystrophy is a pathological state characterized by a complete or partial loss 
of adipose tissue that, occurs in combination with lipid accumulation in ectopic sites in 
the body. Patients with lipodystrophy suffer from metabolic consequences, including 
severe insulin resistance, dyslipidemia, hepatic steatosis, and diabetes mellitus. 
Elucidation of the mechanisms underlying lipodystrophy is expected to help develop 
therapeutic strategies for lipodystrophy and related metabolic complications.  
CNOT3 is a non-catalytic component of the mammalian CCR4-NOT deadenylase 
complex, whose molecular and physiological functions remain to be established. 
Accumulating data suggest that one role of CNOT3 may be related to the control of 
energy metabolism. In this study, I depleted the Cnot3 gene specifically in mouse 
adipose tissues to address its physiological significance in energy metabolism. The loss 
of CNOT3 caused a marked reduction in the amount of white adipose tissue, by contrast, 
loss of CNOT3 caused hypertrophy of brown adipose tissue containing fat-laden cells 
resembling immature white adipocytes. Furthermore, depletion of CNOT3 from adipose 
tissues induced hyperinsulinemia and hyperglycemia that were associated with insulin 
resistance and glucose intolerance. Accordingly, plasma triglyceride levels were 
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elevated and lipids accumulated ectopically in the liver. These results suggested that 
CNOT3 depletion in adipose tissues generated many of the features of lipodystrophy. I 
further found that CNOT3 depletion increased apoptosis in peripheral adipocytes and 
was associated with aberrant fat storage and lipid release; these changes could be a 
direct cause of the lipodystrophic phenotype of adipose tissue-specific Cnot3 knockout 
mice. Finally, to better define the observed lipodystrophic phenotypes, I compared the 
gene expression profiles of adipose tissue-specific Cnot3 knockout mice and two 
phenotypically similar lipodystrophic mouse models, aP2-nSrebp1c mice, which 
overexpress SREBP1, and Ppargldi/+ mice, which conditionally overexpress PPARγ. 
The results revealed a substantial overlap in gene aberrations that could define a 
common signature of lipodystrophy.  
By revealing the lipodystrophic phenotype caused by the deletion of Cnot3 
specifically in adipose tissue, this study provides a novel fundamental basis for better 
understanding the physiological significance of CNOT3 in the control of energy 
metabolism Furthermore, the results of this study raise the intriguing possibility that 
CNOT3 and the CCR4-NOT deadenylase complex could serve as therapeutic targets to 
treat lipodystrophy.  
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Introduction  
Adipose tissue has two essential biological roles in controlling energy balance 
and lipid homeostasis: first, it is the major storage site of excess energy in the form of 
triglycerides and, second, it is an important endocrine organ that synthesizes and 
secretes hormones and adipokines (Kershaw and Flier, 2004). Dysfunction of adipose 
tissue can result in not only obesity (an excess of adipose tissue) but also lipodystrophy 
(a deficiency of adipose tissue). Although these two conditions are opposite 
pathological states of adipose tissue mass, they are both accompanied by similar 
metabolic consequences, including dyslipidemia, hepatic steatosis, severe insulin 
resistance, and diabetes mellitus (Figure 1). Lipodystrophy can be caused by either 
genetic or acquired factors and can be classified as either generalized or partial, 
depending on the degree and locality of the fat (Garg A., 2000). Currently, the most 
common form of lipodystrophy is induced by the protease inhibitors used to treat 
HIV-infected AIDS patients (Hegele et al., 2007; Caron-Debarle et al., 2010) and 
affects up to 50% of the patients. Thus, elucidating the mechanisms that underlie 
lipodystrophy is extremely important for developing therapeutic strategies for not only 
lipodystrophy but also related metabolic complications.  
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The CCR4-NOT complex is an evolutionarily conserved complex that has been 
implicated in the control of multiple steps of mRNA metabolism, including repression 
and activation of transcription, elongation of mRNA, and deadenylation and subsequent 
degradation of mRNA (Collart, 2012). Given these diverse activities, it is not surprising 
that this complex is relevant to a wide range of biological functions. The CCR4-NOT 
complex plays important roles in cell proliferation, apoptosis, oogenesis and 
embryogenesis, spermatogenesis, heart function, bone formation and energy metabolism 
(Collart, 2003; Berthet et al, 2004; Nakamura et al., 2004; Nakashima et al. 2007, 
Morita et al, 2007; Washio-Oikawa et al, 2007). Recent evidence shows that aberrant 
regulation of this complex causes metabolic abnormality, heart disease, and 
osteoporosis (Morita et al., 2011; Neely et al., 2010; Watanabe et al., 2014). CNOT3 is 
a non-catalytic component of the CCR4-NOT complex and is involved in recruitment of 
the CCR4-NOT to the 3' end of specific mRNAs (Morita et al., 2011) (Fig.2). Mice 
haplodeficient in Cnot3 are lean because of poor fat accumulation. Liver size white and 
brown adipose tissues (WAT and BAT, respectively) are reduced in these mice, and 
adipocytes are smaller than those in wild-type mice (Morita et al., 2011). These data 
suggest that Cnot3 has a specific function in liver and adipose tissues. Indeed, a 
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reduction in CNOT3 levels affects the expression of mRNAs that encode proteins that 
are important for lipid metabolism, glucose metabolism, oxidative phosphorylation, and 
growth regulation in the liver (Morita et al., 2011). However, the mechanism by which 
Cnot3 regulates the lipid metabolism in adipose tissue remains unknown.  
In this study, to understand the role of Cnot3 in adipose tissue, and particularly 
the relevance of CNOT3 in fat mass and energy metabolism, I specifically depleted 
Cnot3 from mouse adipose tissue using the cre/loxP system. I show that mice with 
adipose tissue-specific depletion of Cnot3 share many of the features reported in human 
patients with Congenital Generalized Lipodystrophy (CGL) (Agarwal et al., 2006) and 
in other lipodystrophy mouse models (Savage, 2009), such as aP2- nSrebp1c mice (Sr), 
which express a truncated, constitutively active Srebp-1c transgene in adipocytes 
(Shimomura et al. 1998). These features include a marked reduction in the amount of 
white adipose tissue, hypertrophy of brown adipose tissue containing fat-laden cells 
resembling immature white adipocytes, and hyperinsulinemia and hyperglycemia that 
are associated with insulin resistance and glucose intolerance. Accordingly, plasma 
triglyceride levels are elevated, and lipid accumulates ectopically in the liver and other 
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insulin sensitive organs.  
I further provide evidence that CNOT3 depletion increased apoptosis in 
peripheral adipocytes and was associated with aberrant fat storage and lipid release, 
which could be a direct cause of the lipodystrophic phenotype of mice lacking Cnot3 in 
a manner specific to adipose tissue. To examine the underlying mechanisms, I have 
compared the gene expression profiles of wild-type and mice that lack Cnot3in adipose 
tissue. The results show that pathways involved in apoptosis and inflammation were 
significantly up-regulated in mice in which Cnot3 is depleted in adipose tissue. The 
microarray data also revealed that the expression of SREBP (SREBF) target genes was 
up-regulated in the adipose tissues of mice in which Cnot3 is depleted. Taken together, 
these data suggest that Cnot3 depletion in adipose tissue confers the lipodystrophic 
phenotype on mice through apoptosis induction and inflammation and that 
CNOT3-deficiency contributes to lipodystrophy by regulating a subset of mRNAs, 
including Srebp1 mRNA. Thus, CCR4-NOT deadenylase may be a potential therapeutic 
target for lipodystrophy and the metabolic disorders in HIV-associated lipodystrophy 
patients.  
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Materials and Methods 
Mice  
Generation of Cnot3-deficient mice and mice with a floxed Cnot3 locus 
(Cnot3lox/+) were described in previous study (Morita et al., 2011). The Cnot3lox/+ mice 
were backcrossed to C57BL/6J mice for at least 8 generations before interbred to 
generate Cnot3lox/lox mice. Cnot3ad-/- mice were generated by crossing Cnot3lox/lox mice 
with transgenic mice expressing Cre recombinase under the control of the adiponectin 
promoter (Eguchi et al., 2011). Cnot3lox/lox mice were bred with Adipoq-cre mice to 
obtain initially heterozygotes Cnot3lox/+,cre/+. Cnot3lox/+,cre/+ mice were mated with 
Cnot3lox/lox mice to generate Cnot3ad-/- mice. Genotyping was performed by PCR with 
specific primers as follows: wild-type-5’: 5’-CCAGTCTATCTGATGTGGAATTCCTC 
CATG-3’, wild-type-3’: 5’-AGGCTGGCAGCTCCTGGAAAGGCTAAGAGG-3’, Cre 
-5’: 5’-AGCGATGGATTTCCGTCTCT-3’, Cre-5’: 5’-CACCAGCTTGCATGATCT 
CC-3’. PCR amplification of genomic DNA was performed by cycling 30 s at 94 °C, 30 
s at 55 °C, 1 min at 72 °C for 40 cycles. 
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Mice were housed in cages and maintained on a 12-h light–dark cycle, and they 
had access to water ad libitum. Mice were fed a normal chow diet (NCD) (CA-1, CLEA 
Japan Inc.) or a HFD (HFD32, CLEA Japan Inc.). For fasting analysis, mice were 
housed individually and deprived of food for 24 h.  
For cold exposure experiments, mice were housed individually without food and 
bedding immediately before the start of experiments. Mice were allowed free access to 
water and placed at 4 °C while core body temperature was monitored every hour using a 
rectal probe.  
Unless indicated otherwise, male mice at 8–12 weeks of age were used for 
experiments. Experiments were conducted according to the guidelines for animal use 
issued by the Committee of Animal Experiments, Institute of Medical Science, 
University of Tokyo, and Okinawa Institute of Science and Technology Graduated 
School. 
 
Blood analysis 
For glucose tolerance tests, mice were fasted for 16 h. NCD and HFD mice were 
given an intraperitoneal injection of glucose (0.5 mg/g body weight). For insulin 
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tolerance tests, NCD mice and HFD mice were given human insulin (1 mU/g body 
weight). Blood glucose was measured from tail blood using the glucose oxidase method 
(Sanwa Kagaku). Levels of serum triglycerides and insulin were determined using a 
Triglyceride E-Test (Wako) and a Mouse Insulin ELISA Kit (Morinaga), respectively. 
 
Metabolic studies  
Whole-body energy metabolism was evaluated using a Comprehensive Lab 
Animal Monitoring System (CLAMS, Columbia Instruments). Animals were placed 
individually in chambers at ambient temperature (25°C) with 12-h light/dark cycles, 
VO2 is expressed as the volume of O2 consumed per kg0.75 weight per hour. VO2, 
carbon dioxide production, and the respiratory quotient were analysed during a 24-h 
time period. Continuous measurements were obtained over a 72-h time period. Mice 
were acclimated in the chambers for 2 days before the experiment to minimize the 
changes in housing environments. 
For measurement of food consumption, 8-week-old Cnot3ad-/- mice and wild type 
controls (n = 4 each) were housed individually, consumption of foods and body weight 
were measured for 7 consecutive days. For measurement of rectal temperature, an	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electronic thermistor (Model BAT-12) equipped with a rectal probe (RET-3, Physitemp) 
was used as described (Oike et al, 2005). 
The high-fat diet study with 8-week-old Cnot3ad-/- mice and wild type controls (n 
= 4 each) was followed for a period of 12 weeks.  
 
Magnetic Resonance Imaging 
Magnetic resonance imaging with an 11.7 Tesla Magnetic Resonance scanner 
(Bruker, Billerica, MA, USA) was performed on 2% isofluorane-anaesthetized mice. 
The software Fiji (NIH, USA) was used for image analysis. 
 
Histological analysis of tissue 
After dissection, all tissues were fixed in 10% formaldehyde overnight. 
Paraffin-embedded sections were analyzed by haematoxylin and eosin staining. 
Morphometric analysis of adipose tissues from 500 cells per genotype was performed 
with Photoshop. For oil-red-O staining, the liver was frozen embedded. 
 
Antibodies and reagents 
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Rabbit polyclonal antibodies against CNOT1, CNOT3, CNOT6L, CNOT7, and 
CNOT9 were as described (Morita et al, 2007). Mouse monoclonal antibody against 
CNOT3 was purchased from Abnova. Anti-Akt (#9272) and anti-phospho-Akt 
(Ser-473) (#9271) antibodies were purchased from Cell Signaling Technology. 
Anti-tubulin (T9026) and anti-GAPDH (#2118) were purchased from Sigma-Aldrich 
Co. and Cell Signaling Technology, respectively. Anti-perilipin (#9349S) was 
purchased from Cell Signaling Technology. Horseradish peroxidase-conjugated 
anti-rabbit IgG and anti-mouse IgG were from Amersham Biosciences. Human insulin 
was from Eli Lilly and Co.  
 
Immunoblotting 
Tissues were homogenized in lysis buffer (1% NP-40, 50mM Tris–HCl (pH 7.5), 
150mM NaCl, 1mM EDTA, 1mM phenylmethylsulfonyl fluoride, 1mM NaF, 1mM 
Na3VO4) using a glass homogenizer and centrifuged for 10 min at 4℃. Protein 
concentrations were measured by the Bio-Rad protein assay. Proteins in the lysates were 
electrophoresed in SDS-polyacrylamide gel and then transferred onto Immobilon-P 
membranes (Millipore). Immunoblots were probed with the appropriate antibodies. 
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RNA analysis 
For real-time PCR, total RNAs (1µg) were used for reverse transcription with 
oligo(dT) 12–18 primer (Invitrogen) using the SuperScript III First-Strand Synthesis 
System (Invitrogen). Real-time quantitative PCR reactions were carried out using 
SYBR Premix Ex Taq (Takara) and the ABI PRISM 7900HT Sequence Detection 
System (Applied Biosystems). 36B4 mRNA levels were used for normalization.  
To measure mRNA stability, cells were treated with actinomycin D (5 mg/ml), and total 
RNAs were extracted at the indicated time points and subjected to qPCR analysis. The 
amount of reporter mRNAs was normalized to that of 36B4 mRNA. 
 
Preparation of Primary MEF Cells 
Primary MEF cells were isolated from E14.5 embryos. Embryos were removed 
and separated from maternal tissues and yolk sack and were finely minced, digested 
with 0.05% trypsin/ 1 mM EDTA for 30 min at 37°C, and centrifuged for 5 min at 
1000g. The pellet was resuspended in culture medium before plating. Cells were 
cultured at 37 °C in high glucose DMEM containing 10% FBS and 100 units/ml 
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penicillin/streptomycin (Invitrogen). Experiments were performed at passage 2.  
 
Adipocyte differentiation 
White adipocyte differentiation was induced by treating confluent cells with 
medium containing 10% FBS, 0.5 mM methylisobutylxanthine, 1µMdexamethasone 
(DEX), 5 µg/ml insulin. Two days after induction, the medium was replaced with the 
maintenance medium containing 10% FBS, 5 µg/ml insulin. Brown adipocyte 
differentiation was induced by treating confluent cells with DMEM containing 10% 
FBS, 0.5mM isobutylmethylxanthine, 125 mM indomethacin, 2 mg/ml dexamethasone, 
5 µg/ml insulin, 1 nM T3 and 0.5 mM rosiglitazone. Two days after induction, cells 
were switched to the maintenance medium containing 10% FBS, 5 µg/ml insulin, 1nM 
T3 and 0.5 mM rosiglitazone. Medium was renewed every 2 days.  
 
Oil-red-O staining.  
After 8 days of differentiation, cells were washed once in phosphate-buffered 
saline and fixed with 10% neutral buffered formalin solution (Sigma) for 15 min. The 
staining solution was prepared by dissolving 0.3 g oil-red-O (Sigma) in 100 ml of 
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isopropanol; before using, dilute six parts Oil Red-O stock with four parts distilled 
water, after 1 h at room temperature, the staining solution was filtered and added to 
dishes for 4 h. The staining solution was then removed, and cells were washed twice 
with distilled water.  
 
Immunohistochemistry 
Immunohistochemistry was performed using 4µm thick formalin-fixed, 
paraffin-embedded tissue sections. Briefly, slides deparaffinized in xylene were passed 
through graded alcohols and into PBS. Slides were then pretreated with 10 mM sodium 
citrate buffer, pH 6.0 kept at 121°C for 15 min using an autoclave (TOMY), followed 
by washing in PBS. Subsequent steps were performed at room temperature in a 
hydrated chamber. Slides were immersed in 3% H2O2 solution in absolute methanol at 
RT for 15 min to quench endogenous peroxidase activity. For macrophage staining: 
monoclonal rat anti-murine Mac2 (clone M3/38, Cedarlane) at 1:1000 was used. For 
apoptosis: monoclonal rabbit anti-murine Caspase3 antibody (Cell Signaling #9664) at 
1:100 was used. For perilipin, monoclonal rabbit anti-perilipin (Cell Signaling #9349) at 
1:100 was used. Slides were washed in PBS, and detected with with N-Histofine® 
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Simple Stain Rat or Rabbit MAX PO (M) respectively. After further washing, brown 
immunoperoxidase staining was developed using a DAB chromogen (N-Histofine) and 
counterstained with hematoxylin (blue). Slides were examined and images were 
acquired with a fluorescence microscope (BZ-9000 All-in-one, KEYENCE). 
 
Lipolysis assay 
Epididymal fat pads from 4-5 mice were collected and digested in a digestion 
buffer (121 mM NaCl, 4.9 mM KCl, 1.2mM MgSO4, 0.33 mM CaCl2, 12 mM HEPES) 
containing dipase II (2.4 Uml-1), collagenese D (1.5 Uml-1), 3 mM glucose and 1 % 
fatty-acid-free BSA (Sigma). After digestion for 40 min at 37 °C with shaking, 
adipocytes were filtrated through nylon mesh and centrifuged at 200 g for 5 min. 
Floating adipocytes were collected and incubated in DMEM containing 10 % FBS with 
or without isoproterenol (1 mM) for 1.5 h at 37 °C. Glycerol released into the media 
was determined by using a free glycerol reagent (Sigma), the amounts of glycerol were 
normalized to the total protein content of the adipocytes by using a Pierce BCA Protein 
Assay reagent (Thermo Scientific). 
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Microarray analysis 
Total RNAs were extracted with ISOGEN according to the manufacturer’s 
protocol (Nippon Gene) and purified with an RNeasy Kit (Qiagen). cDNA and 
biotin-labelled cRNA were synthesized according to the protocols from Affymetrix. 
After fragmentation of cRNA, 20 mg biotin-labelled cRNA was hybridized to the 
GeneChip Mouse Genome 430 2.0 Array. To determine the average difference for each 
probe set, a global normalization method (Robust Multi-array Average) was used. 
Selected probe set IDs were converted to the manufacture’s annotation. Enrichment of 
pathway was analyzed by Fisher’s exact test followed by Bonferonni’s correction. 
Microarray data of aP2- nSrebp1c mice (Sr) and Ppargldi/+ mice was obtained from the 
Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. 
GSE9132). 
Statistical analyses 
All values represent mean values ± standard error of the mean (SEM). 
Differences between groups were examined for statistical significance using Student’s 
t-test (two tailed distribution with two-sample equal variance). P<0.05 was considered 
significant throughout the study.  
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Results 
Targeted deletion of Cnot3 in mouse adipose tissues 
To understand the role of Cnot3 in adipose tissue, I generated mice in which Cnot3 
was knocked out specifically in adipose tissues (hereafter referred to as Cnot3ad-/-). 
LoxP sites were introduced on either side of exons 2-9 of Cnot3 to generate floxed 
Cnot3 mice (Cnot3lox/lox) (Morita et al., 2011), and these mice were crossed with 
Adipoq-cre mice that express Cre recombinase under the control of the 
mouse adiponectin (Adipoq) promoter (Eguchi et al., 2011) (Figure 3). Immunoblotting 
confirmed the absence of CNOT3 expression specifically in white adipose tissue 
(WAT) and interscapular brown adipose tissue (BAT) (Figure 4A), with unaltered 
CNOT3 expression in the liver, spleen and other tissues (Figure 4B).  
 
Cnot3ad-/- mice exhibit lipodystrophy 
Cnot3ad-/- mice were born at the expected Mendelian frequency, and there were no 
obvious morphological differences from control mice (Figure 5A). Although Cnot3 
haplodeficient mice were lean, Cnot3ad-/- mice were unexpectedly normal in size on a 
chow diet. Surprisingly, the total body weight of Cnot3ad-/- mice was slightly increased 
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compared with controls (Figure 5B). Dissection of Cnot3ad-/- mice revealed the 
following: (1) severely reduced epididymal WAT pads (eWAT) (Figure 6A) and 
subcutaneous, retroperitoneal, and mesenteric WAT pads (scWAT, rWAT, mWAT) 
(Figure 6B); and (2) markedly increased interscapular brown adipose tissue (BAT) 
(Figures 7A and B) that was pale in appearance. The sizes of other tissues in Cnot3ad-/- 
mice were not different from wild-type mice. Whole-body magnetic resonance imaging 
(MRI) analysis revealed a significant and global reduction in white adipose tissue mass, 
including subcutaneous, perigonadal, and mesenteric depots (Figures 7B and C). By 
contrast to the gross loss of WAT, cross-sectional examination of the interscapular 
region revealed enlarged BAT depots with increased lipid content (Figure 7A). 
Comparison of Cnot3ad-/- mice and wild-type control mice by histological analysis 
using hematoxylin and eosin (H&E) staining revealed the following: (1) Cnot3ad-/- mice 
showed irregular sizes of white adipocytes and fibrotic WAT stroma (Figures 8A and 
B); (2) brown adipocytes in Cnot3ad-/- mice contained unilocular lipid deposition similar 
to that seen in immature white adipocytes (Figures 8C and D); and (3) increased lipid 
droplet accumulation was observed in hepatocytes from Cnot3ad-/- mice (Figures 8E and 
F). Oil-Red-O staining confirmed excessive hepatic lipid accumulation in Cnot3ad-/- 
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mice compared with their wild-type littermates (Figures 8G and H). These observations 
suggested abnormal lipid accumulation in the liver and BAT of Cnot3ad-/- mice. Notably, 
these phenotypes of Cnot3ad-/- mice shared many of the features reported in human 
patients with Congenital Generalized Lipodystrophy (CGL) (Agarwal et al., 2006) and 
in mouse models of lipodystrophy, particularly aP2-nSrebp1c mice (Sr) (Shimomura et 
al. 1998). 
To further confirm the lipodystrophic phenotype of Cnot3ad-/- mice, I compared the 
levels of circulating metabolic parameters between wild-type and Cnot3ad-/- mice. 
Cnot3ad-/- mice displayed typical metabolic sequelae of lipodystrophy, including 
hyperinsulinemia (Figure 9A), increased levels of circulating triglycerides (Figure 9B), 
hyperglycemia under fasting condition (Figure 9C), glucose intolerance (Figure 9D) and 
severe insulin resistance (Figure 9E).  
 
 
Impaired thermogenic responses in Cnot3ad-/- mice 
In rodents, one of the key mechanisms for heat generation and energy dissipation 
is thermogenesis in BAT (Seale et al., 2009). Given the hypertrophy and unilocular lipid 
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deposition in Cnot3ad-/- BAT, I hypothesized that BAT function was impaired. In the 
BAT of Cnot3ad-/- mice, expression of the BAT-specific uncoupling protein gene Ucp1 
was significantly decreased (Figures 10A and B). This change in BAT architecture 
suggested that, in an effort to increase their fat storage capabilities, Cnot3ad-/- mice 
transdifferentiate BAT to a more WAT-like phenotype. To address this possibility, the 
expression of the white fat markers HoxC8 and Dpt in BAT were analyzed using 
qRT-PCR (Sanchez-Gurmaches et al., 2012). Indeed, the BAT of Cnot3ad-/- mice 
showed higher expression of the white fat markers HoxC8 and Dpt compared with 
wild-type mice (Figure 10C).   
Because the BAT of Cnot3ad-/- mice appeared to be dysfunctional as a result of 
excess lipid accumulation, I assumed that thermogenesis in Cnot3ad-/- mice was 
impaired. Direct measurement of resting core body temperatures showed no significant 
differences between Cnot3ad-/- and wild-type mice (Figure 11A). To further assess 
thermogenic capacity and determine whether increased adaptive thermogenesis 
contributes to the enhanced energy expenditure in Cnot3ad-/- mice, we exposed 
8-week-old Cnot3ad-/- and wild-type mice to a 4°C environment. Whereas wild-type 
mice maintained their body temperature at approximately 35.0°C during a 5 h cold 
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exposure, Cnot3ad-/- mice were intolerant to cold exposure and their body temperature 
dropped to 30°C by the end of a 5 h cold exposure (Figure 11B). These observations 
suggest that Cnot3 deficiency impaired acute cold-induced thermogenesis.  
 
Increased energy expenditure in Cnot3ad-/- mice 
     Because reduced adiposity indicates an energy balance disorder, it was necessary 
to address whether the reduced white adipose tissue size in Cnot3ad-/- mice resulted from 
increased energy expenditure. The energy available in food can be liberated in the body 
only as a result of oxidations, which ultimately depend on a supply of oxygen from the 
air, thus, a measurement of the oxygen uptake by the body is also a measure of energy 
expenditure (Durnin, 1984). Oxygen consumption (VO2) and carbon dioxide 
production (VCO2) occur during the oxidation of carbohydrate, protein, and fat. Heat 
production can be calculated from a measurement of VO2 and/or VCO2 
(SparkNotes.com, 2014). I measured food intake and found that the rate of food intake 
per day was similar between Cnot3ad-/- and wild-type chow-fed mice (Figure 12). Next, 
whole-body energy metabolism was measured by monitoring oxygen consumption. 
Deletion of CNOT3 in adipose tissues resulted in increased oxygen consumption and 
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carbon dioxide production compared with control mice (Figures 13A, B, C and D). The 
respiratory exchange ratio (RER) did not show significant differences in fuel source 
usage (Figures 13E and F). These observations demonstrated that the deletion of 
CNOT3 in adipose tissues enhanced energy expenditure.  
Because Cnot3ad-/- mice have smaller adipose stores (Figures 5 and 6), they 
assumed to exhibit symptoms of cold stress even at 22°C. Indeed, Ucp1 mRNA levels 
in the white adipose tissue of Cnot3ad-/- mice housed at 22°C were markedly elevated 
(Figure 14), suggesting exaggerated cold stress. Thus, the increased metabolic rate in 
Cnot3ad-/- mice might be a compensatory response to maintain normal body temperature 
in the absence of white adipose tissue. An increased resting energy expenditure (REE) 
also has been observed in human lipodystrophy syndromes (Cutler et al., 1991; Klein et 
al., 1992; Kosmiski et al., 2001). The increased energy expenditure in human 
lipodystrophy syndromes seems to be an adaptive response to an inability to store 
triacylglycerol fuel in a normal manner, which may represent a defense mechanism to 
protect non-adipose tissues from further lipid accumulation (Kosmiski et al., 2007). 
 
Impaired lipolysis in the adipocytes of Cnot3ad-/- mice 
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Because an increased lipolysis rate results in reduced adiposity, I next performed 
an ex vivo lipolysis assay to examine whether the lipolysis rate was increased in the 
WAT of Cnot3ad-/- mice. Primary adipocytes from the epididymal fat pads of wild-type 
and Cnot3ad-/- mice were isolated, and their lipolysis rates were compared. 
Unexpectedly, primary adipocytes from Cnot3ad-/- mice showed severely impaired 
lipolysis (Figure 15). These observations suggested that the reduced adiposity in 
Cnot3ad-/- mice was not caused by increased lipolysis. 
 
Adipose tissue inflammation and apoptosis in Cnot3ad-/- mice 
The white adipose tissue of Cnot3 ad-/- mice was unusual, having mononuclear cell 
infiltration and fibrotic stroma. The presence of inflammatory cell infiltration was 
further evaluated using quantitative RT-PCR. The expression of mRNAs corresponding 
to macrophage-related proteins were elevated in epididymal WAT and BAT from 
Cnot3ad-/- mice; these proteins included the chemokine MCP-1, the surface antigen 
Emr1 (recognized by an F4/80 antibody), and the macrophage transcription factor PU.1 
(Figures 16A and B). Immunohistochemistry for MAC-2 (also known as galectin-3), a 
lectin expressed by activated macrophages that mediates macrophage phagocytic and 
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inflammatory responses, identified an increased number of MAC-2-positive 
macrophages in both epididymal WAT and BAT from Cnot3 ad-/- mice compared with 
wild-type littermates. Macrophages in the surrounding remnants of lipid droplets of 
adipocytes were sometimes observed to form crown-like structures (CLSs) in the WAT 
of Cnot3 ad-/- mice, whereas these structures were almost absent from the WAT of 
wild-type mice (Figures 16C and D). Dramatically increased numbers of macrophages 
were also present and formed CLSs near adipocytes in the BAT of Cnot3 ad-/- mice 
(Figures 16E and F). 
The appearance of macrophages in the WAT and BAT of Cnot3 ad-/- mice 
suggested the presence of at dead adipocytes. To confirm this, immunohistochemistry 
was performed using an antibody against perilipin, an essential protein that coats lipid 
droplets. The absence of perilipin staining indicates dead or dying adipocytes. The 
results showed that the number of perilipin-negative cells in the epididymal WAT of 
Cnot3ad-/- mice was increased compared with littermate controls (Figures 17A and B), 
indicating that adipocytes were dying in the epididymal WAT of Cnot3ad-/- mice. 
Perilipin immunohistochemistry demonstrated that CLSs were selectively formed near 
perilipin-free adipocytes that lacked an intact plasma membrane. 
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I next tried to determine the causes of adipocyte death and the decrease in the 
size of white adipose tissue in Cnot3ad-/- mice. Immunohistochemical staining with 
anti-cleaved-caspase-3 antibodies revealed that the numbers of apoptotic cells in both 
WAT and BAT from Cnot3ad-/- mice were increased compared with control littermates 
(Figures 18A-D). The data suggested that adipocyte death was accelerated in the 
diminished WAT and hypertrophic BAT of Cnot3ad-/- mice. The massive apoptosis of 
metabolically active adipocytes clearly demonstrates that adipocyte destruction is the 
dominant pathological process involved in the loss of adipose tissue. It was 
hypothesized that increased apoptosis of peripheral adipocytes with impaired fat storage 
and lipid release may cause the lipodystrophic phenotype of Cnot3 ad-/- mice. Microarray 
analysis was conducted to compare the gene expression profiles of epididymal fat pads 
in Cnot3ad-/- mice and their wild-type littermates. The results showed that pathways 
involved in apoptosis and inflammation were significantly up-regulated in Cnot3ad-/- 
mice (Table 1). The microarray data also revealed that expression of the 
SREBP/SREBF target gene was up-regulated. I focused on this gene because mice 
overexpressing the constitutively active Srebp-1c (one of the isoforms of Srebp1) 
transgene in adipocytes showed the same lipodystrophic phenotype (Shimomura et al., 
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1998). Quantitative RT-PCR analysis confirmed that the expression level of Srebp1 was 
significantly up-regulated in both WAT and BAT of Cnot3ad-/- mice (Figures 29A and 
B).  
 
Common alterations in gene expression between Cnot3ad-/- mice and other 
lipodystrophy models 
To further characterize the lipodystrophic phenotype in Cnot3ad-/- mice, compared 
the gene expression profiles of Cnot3ad-/- mice with those of two lipodystrophy model 
mice: aP2- nSrebp1c mice (Sr), which express the constitutively active Srebp-1c 
transgene in adipocytes, and Ppargldi/+ mice, which are generated by inserting the Tet 
activator (tTA) and a tTA-regulated Flag-Pparg1 transgene into the Pparg gene. In total, 
772, 722 and 751 transcripts were up-regulated >2.5-fold in the WAT of Cnot3ad-/-, 
Ppargldi/+ and Sr epididymal fat pads, respectively, relative to their wild-type littermates 
(Figure 20). Of these, 100 genes were common among the three strains (Table 3). This 
substantial overlap in gene expression change may indicate widespread similarities in 
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the molecular basis of the lipodystrophic phenotype among the three strains, and those 
common genes may represent a typical signature of lipodystrophic fat.  
 
Resistance to diet-induced obesity and enhanced energy expenditure in Cnot3ad-/- 
mice 
Because Cnot3ad-/- mice exhibited reduced fat mass and increased energy 
expenditure under chow-fed condition, I next determined whether they would be 
resistant to weight gain when challenged with a high-fat diet. Cnot3ad-/- mice and 
wild-type littermates were fed a high-fat diet (HFD) for 3 months. During HFD feeding, 
Cnot3ad-/- mice gained significantly less weight than their wild-type littermates (Figure 
21A and B). At the end of the HFD period, the net weight gains of wild-type and 
Cnot3ad-/- mice were 18.15 ± 0.68 g and 9.73 ± 1.39 g, respectively (Figure 21C). 
Cnot3ad-/- mice fed an HFD exhibited exacerbated lipodystrophy symptoms; their white 
adipose tissue size was dramatically reduced and brown adipose tissue was extremely 
hypertrophic compared with their wild-type littermates (Figures 22A and B). 
Whole-body magnetic resonance imaging (MRI) studies confirmed the exacerbated 
lipodystrophy in Cnot3ad-/- mice (Figure 23).  
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The observed resistance to obesity in Cnot3ad-/- mice suggested altered food 
intake or energy metabolism. Higher energy expenditure was observed by indirect 
calorimetry during both day and night cycles in Cnot3ad-/- mice (Figures 24A and B), 
even when their food intake was significantly increased (Figure 25A). The increase in 
oxygen consumption on the high-fat diet was approximately 17.4±0.5% and 17.1±0.6% 
during the light and dark phases, respectively. No differences were observed in the 
respiratory exchange ratio (RER) (Figures 24E and F). Despite increased energy 
expenditure, there was no difference in core body temperature between wild-type and 
Cnot3ad-/- mice (37.1±0.3°C and 37.5±0.2°C, respectively) (Figure 25B). These 
observations suggest that the Cnot3ad-/- mice were protected from obesity on a high-fat 
diet because of a significant increase in energy expenditure. The maintenance of normal 
body temperature despite increased energy expenditure indicated that because of the 
exacerbated lipodystrophy, increased energy expenditure is an adaptation to maintain 
body temperature in the absence of WAT. 
Glucose and insulin tolerance tests were then performed in Cnot3ad-/- and 
wild-type mice. Surprisingly, in contrast to other models of lipodystrophy that exhibited 
exacerbated metabolic disorders when fed an HFD (Agarwal et al., 2006; Villena et al., 
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2008), HFD-fed Cnot3ad-/- mice exhibited improved glucose tolerance and comparable 
insulin resistance compared with their wild-type littermates (Figures 26A and B). 
Morphological examination revealed that although the adipocytes of Cnot3ad-/- mice 
WAT were significantly smaller than those of wild-type mice (Figures 27A and B), 
lipid accumulation in the BAT and liver were at the same level compared with 
wild-type littermates (Figures 27C-F). Taken together, these observations indicate that 
although Cnot3ad-/- mice fed an HFD exhibited exacerbated lipodystrophy, but the 
metabolic consequences, such as glucose intolerance, insulin resistance and ectopic 
lipid accumulation, were not exacerbated compared with wild-type littermates.
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Discussion 
The CCR4-NOT complex contains at least 10 subunits. Aberrant regulation of 
several subunits of this complex, including CNOT1, CNOT3, CNOT6, CNOT6L, 
CNOT7, and CNOT8, has been implicated in the development of metabolic disorders 
(Morita et al., 2010; unpublished data). Whereas Cnot3+/- mice show defects in energy 
metabolism (Morita et al., 2010), there is no information about the effects of complete 
loss of Cnot3 in metabolic tissues. To better understand the role of Cnot3 in nutrient 
signaling and energy metabolism, I generated a mouse strain lacking Cnot3 specifically 
in adipose tissue using the cre/loxP system. Cnot3 deficiency in adipose tissues induces 
lipodystrophy, a rare disease characterized by a deficiency of adipose tissue. 
Lipodystrophy is caused by multiple factors. Recent studies showed that 
lipodystrophy can result from either the suppression or the overexpression of various 
genes; several lipodystrophic mouse models have been generated by disrupting 
transcription factor-coding genes, including peroxisome proliferator activated receptor 
(PPAR)γ (He W et al., 2003), sterol regulatory element binding protein (SREBP)1c 
(Shimomura I et al., 1998), and CCAAT/enhancer-binding proteins (C/EBPs) 
(Chatterjee R et al., 2010). In this study, I provide evidence that impairment of 
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CCR4-NOT deadenylase complex, another regulator of gene expression, induces a 
lipodystrophic phenotype. I further provide evidence that Cnot3 deficiency caused 
massive inflammation and apoptosis in adipose tissues, which together at least partially 
account for the lipodystrophic phenotype. Furthermore, Cnot3 might target mRNAs 
related to lipodystrophy, such as Srebp1 mRNA, so that CCR4-NOT can deadenylate 
these mRNAs.  
Mice showing haploinsufficiency of the Cnot3 in whole body are lean with 
decreased adiposity and have increased metabolic rates and enhanced glucose tolerance 
(Morita et al., 2010). Deletion of Cnot3 in an adipose tissue-specific manner caused 
massive fat loss, but these mice are not lean and show insulin resistance and impaired 
glucose tolerance, suggesting that the balance of Cnot3 expression in adipose tissue has 
a very important role in maintaining adipocyte viability and whole body metabolism.  
Lipodystrophy is commonly ascribed to defective adipocyte differentiation (Garg 
A et al., 2004; Capeau J et al., 2005; Moitra J et al., 1998; Shimomura I et al., 1998; 
Peterfy M et al., 2001). Because the Cre transgenic mice I used to generate Cnot3ad-/- 
mice express Cre recombinase only in mature adipocytes, the differentiation of 
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adipocytes should not have been impaired; therefor, the fat loss and subsequent 
progressive lipodystrophy in Cnot3ad-/- mice are not due to defective adipocyte 
differentiation.  
The phenotype of Cnot3ad-/- mice is similar to that of the established 
lipodystrophy model, aP2-nSREBP-1c transgenic mice (Shimomura et al. 1998) , which  
have the unique combination of hypoplastic WAT and hypertrophic BAT. These traits 
and their metabolic consequences resemble the HIV-associated lipodystrophy of 
patients under combined antiretroviral therapy (cART) against HIV infection, in which 
peripheral fat depots degenerate and visceral, neck (buffalo hump) and breast fat depots 
expand (Carr A et al., 1998; Grinspoon et al., 2005). Our results demonstrate that 
Cnot3ad-/- mice constitute an interesting experimental model to understand the molecular 
basis of lipodystrophy induced by cART in humans. Further studies are required to 
addres the relationship between hypoplastic WAT and hypertrophic BAT. BAT-specific 
KO of Cnot3 would provide more conclusive evidence for the role of Cnot3 in this 
tissue. 
Cnot3ad-/- mice exhibited severe insulin resistance (Figure 10E). Alterations in 
adipocyte functions, such as the capacity to store lipids and secrete adipokines, and 
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ectopic accumulation of lipids in tissues other than adipose tissue are considered to be 
major causes of the development of insulin resistance (Shulman, 2000; Villena et al., 
2008). In addition, hyperlipidemia and the appearance of insulin resistance are often 
associated with the activation of inflammatory pathways (Wellen et al., 2005). 
Therefore, altered inflammatory pathways in Cnot3ad-/- mice may contribute to their 
insulin resistance. 
Cnot3ad-/- mice also exhibited increased energy expenditure. This finding is 
consistent with other reports of increased resting energy expenditure (REE) in humans 
with lipodystrophy syndromes (Cutler et al., 1991; Klein et al., 1992; Kosmiski et al., 
2001). Acute cold-induced thermogenesis was impaired in Cnot3ad-/- mice, suggesting 
that the increased metabolic rate of Cnot3ad-/- mice may not be a direct consequence of 
Cnot3 deficiency but rather a compensatory response to maintain normal body 
temperature in the absence of white adipose tissue. 
Furthermore, deletion of Cnot3 in adipose tissue prevents the body weight gain 
and adipose tissue accumulation that are normally associated with high-fat diets. Unlike 
other models of lipodystrophy that show exacerbated metabolic disorders under high-fat 
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feeding conditions (Agarwal et al., 2006; Villena et al., 2008), Cnot3ad-/- mice fed an 
HFD exhibited exacerbated lipodystrophy, but the metabolic consequences of this 
lipodystrophy, such as glucose intolerance, insulin resistance and ectopic lipid 
accumulation, were not exacerbated compared with wild-type littermates. It was 
hypothesized that the increased energy expenditure might be an adaptive response to an 
inability to store triacylglycerol fuel in a normal manner, which may represent a defense 
mechanism to protect non-adipose tissues from further lipid accumulation (Kosmiski et 
al., 2007). The mechanism underlying this phenotype was not investigated further, but 
deserves additional studies.  
In conclusion, this study describes the lipodystrophic phenotype caused by the 
deletion of Cnot3 specifically in adipose tissue. Microarray analysis revealed that a 
reduction in CNOT3 levels specifically in adipose tissue affects the expression of 
mRNAs that encode proteins important for lipid metabolism, inflammation, and 
apoptosis. Thus, the Cnot3ad-/- mice may be a novel valuable animal model of partial 
lipodystrophy and insulin resistance in humans. Overall, this study links CCR4-NOT 
complex function to lipodystrophy syndrome for the first time, and our findings raise 
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the intriguing possibility that CNOT3 and the CCR4-NOT deadenylase complex can 
serve as therapeutic targets to treat lipodystrophy and its associated metabolic disorders.   
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Figure 1. Schematic illustration of lipodystrophy. Lipodystrophy and obesity are caused by 
different etiology but accompanied by similar metabolic consequences including dyslipidemia, 
hepatic steatosis, severe insulin resistance, and diabetes mellitus. 
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Figure 2. Schematic illustration of the CCR4-NOT complex and the role of CNOT3. The 
CCR4–NOT complex is a major deadenylase that regulates mRNA degradation by catalyzing 
the removal of mRNA poly(A) tails. The CNOT3 non-catalytic component of the mammalian 
CCR4-NOT complex is involved in recruitment of the CCR4-NOT to the 3' end of specific 
mRNAs.  
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Figure 3. Targeted disruption of the Cnot3 gene in adipose tissues.  
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Figure 4.(A) Western blot of CNOT3 and α-Tubulin protein by western blot in white 
adipose tissue (WAT) and brown adipose tissue (BAT) of Cnot3lox/lox control and Cnot3ad-/- 
mice. (B) Tissue distribution of CNOT3 protein by western blot in Cnot3lox/lox control and 
Cnot3ad-/- mice. .	
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Cnot3lox/lox	 Cnot3ad-/-	
Figure 5. There were no obvious morphological differences in Cnot3ad-/- mice. (A) Gross 
appearance of 8-week-old Cnot3ad-/- mice and their wild-type littermates on ND feeding. 
(B) Growth curve of Cnot3ad-/- mice and their wild-type littermates from 2 to 8 weeks 
after birth. n=10 for each genotype. Results expressed as mean ± SEM, *p < 0.05, * * p < 
0.01, * * * p < 0.001.	
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A
Figure 6. Severely reduced size of WAT and markedly enlarged BAT.(A) Fat pads 
morphology of wild-type and Cnot3ad-/- mice. (B) The relative weight of the indicated 
organs. The weight of the organ was normalized to body weight. n=8-10 for each 
genotype. Results expressed as mean ± SEM, *p < 0.05, * * p < 0.01, * * * p < 0.001. 	
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Figure 7. MRI imaging of wild-type (left) and Cnot3ad-/- (right) mice at 8 weeks on ND 
feeding. Cross-section at the level of the interscapular region (A), thorax (B) and 
abdomen (C). D, diaphragm; scWAT, subcutaneous WAT; mWAT, mesenteric WAT; 
pWAT, retroperitoneal fat; BAT , Interscapular BAT; SC, spinal cord;. K, kidney.	
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Figure 8. An abnormal lipid accumulation in the liver and BAT of Cnot3ad-/- mice. 
Histologic sections of WAT BAT and liver of 8-week-old wild type and Cnot3ad-/- mice. 
(A-F), HE staining of WAT BAT and liver, (G,H) oil-red-O staining of liver. Scale bar, 
100μm. 	
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Figure 9. Typical metabolic sequelae of lipodystrophy in Cnot3ad-/-  mice. (A) Serum  
insulin concentration (B) Serum triglyceride concentration (C) Blood glucose levels in fed 
or fasted  Cnot3lox/lox and Cnot3ad-/- mice. (D and E) Glucose tolerance tests (GTTs) (D) 
and Insulin tolerance tests (ITTs) (E) in wild-type and Cnot3ad-/- mice fed on ND. Blood 
glucose levels were measured at each indicated time point following intraperitoneal 
injection of 0.5 g glucose per kg body weight or 1.0 U insulin per kg body weight. n=6–
10 for each genotype. Results expressed as mean ± SEM, *p < 0.05, * * p < 0.01, * * * p 
< 0.001.	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Figure 10. (A) qRT-PCR analysis of Ucp1mRNA expression level in BAT of Cnot3ad-/- 
mice and their wild-type littermates. (B) UCP1 protein expression level in BAT of 
Cnot3ad-/- mice and their wild-type littermates. (C) qRT-PCR analysis of HoxC8 and Dpt 
in BAT of Cnot3ad-/- mice and their wild-type littermates.*P<0.05; **P<0.01 and 
***P<0.001.	
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Figure 11. Cnot3 deficiency impaired acute cold-induced thermogenesis.(A) Core body 
temperature of Cnot3ad-/- mice and their wild-type littermates. (B) Time course of core 
body temperature of Cnot3ad-/- mice and their wild-type littermates housed at 4°C. n=5 for 
each genotype. *P<0.05; **P<0.01 and ***P<0.001.	
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Figure 12. Average daily food was no different between Cnot3ad-/- mice and their wild-
type littermates. Average daily food intake normalized to body weight. Daily food intake 
per mouse was measured over 7 days. n=10 for each genotype. n=10 for each genotype. 	
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Figure 13. Increased energy expenditure in Cnot3ad-/- mice. (A and B) Oxygen 
consumption (VO2) over 24 hr (A) and average VO2 (B) in wild-type and Cnot3ad-/-  mice 
fed on ND. (C and D) CO2 production (VCO2) over 24 hr (C) and average VCO2 (D) in 
wild-type and Cnot3ad-/-  mice fed on ND. (E and F) Respiration exchange ratio (RER) 
over 24 hr (E) and average RER (F) in wild-type and Cnot3ad-/-  mice fed on ND. The data 
were normalized to body weight. n = 4 per group. (C and D) respiratory exchange ratio 
(RER)	  . n = 4 per group. *p < 0.05, **p < 0.01 *** p < 0.001	
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Figure 14.	  Cnot3ad-/- mice exhibited symptoms of cold stress even at 22°C. qRT-PCR 
analysis of Ucp1mRNA expression level in epididymal WAT of Cnot3ad-/- mice and 
their wild-type littermates. n=5 for each genotype. *P<0.05; **P<0.01 and 
***P<0.001.	
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Figure 15. Cnot3ad-/- mice exhibited decreased  lipolysis in vitro.	  (A) Rate of lipolysis in 
isolated adipocytes. Adipocytes were isolated from epididymal fat of male Cnot3ad-/- mice 
and their wild-type littermates. Glycerol was measured in the absence and presence of 10 
mM of isoproterenol. n=4 for each genotype. Results are expressed as mean ± SEM,  *p < 
0.05, * * p < 0.01, * * * p < 0.001 (n = 4). 
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Figure 16. Inflammation and macrophages in adipose tissues of Cnot3ad-/- mice. 
Quantitative RT-PCR analysis of MCP-1 PU.1 and F4/80 in WAT (A)  BAT(B) of 
Cnot3ad-/- mice and their wild-type littermates. Histological sections of epididymal WAT 
and BAT from 8 weeks old male Cnot3ad-/-  and WT littermate. Immunohistochemical 
localization of macrophages in epididymal WAT(C,D) and BAT (E,F), arrowhead 
indicates crown-like structures (CLS). *P<0.05; **P<0.01 and ***P<0.001. Scale bar, 
100μm.	
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Figure 17.  Adipocytes cell death in WAT of Cnot3ad-/- mice. (A,B)Histological sections of 
epididymal WAT from 8 weeks old male Cnot3ad-/- and WT littermate. Sections were 
stained with anti-perilipin antibody followed by colorimetric detection (brown) and 
counterstaining with hematoxylin (blue).  White asterisk indicates dying adipocytes with 
perilipin-negative lipid droplets. Scale bar, 100µm. (C) Protein expression levels in WAT. 
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Figure 18.  Adipocytes apoptosis. Histological sections stained for apoptosis with anti-
cleaved caspase 3 antibody (brown) and counterstaining with hematoxylin (blue) in 
epididymal WAT(A,B) and BAT (C,D). Arrowhead indicates adipocytes with activated 
capase 3. Scale bar, 100µm. 	
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Figure 19. The expression level of Srebp1 were significantly up-regulated in both WAT 
and BAT of Cnot3ad-/- mice. qRT-PCR analysis of Srebp1mRNA expression level in 
WAT(A)and BAT (B) of Cnot3ad-/- mice and their wild-type littermates. *P<0.05; 
**P<0.01 and ***P<0.001.	
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Figure 20. Overlapping gene expression in Cnot3ad-/- , aP2-nSrebp1c and Ppargldi/+ fat. 
Venn diagram depicting the numbers of overlapping and strain specific genes that are 
upregulated more than 2.5-fold in these strains. 	
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 Cnot3ad-/-	A
Figure 21. Resistance to high-fat diet-induced obesity. (A) Gross appearance and (B) 
growth curve of 20-week-old Cnot3ad-/- mice and their wild-type littermates after HFD 
feeding. (C) Gains of body weight of wild-type and Cnot3ad-/- mice were calculated from 
(B). n=10 for each genotype. *P<0.05; **P<0.01 and ***P<0.001.	
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Figure 22. Exacerbated lipodystrophy in HFD-fed Cnot3ad-/- mice. (A) Fat pads 
morphology of wild-type and Cnot3ad-/- mice. (B) The relative weight of the indicated 
organs. The weight of the organ was normalized to body weight. n=10 for each genotype. 
*P<0.05; **P<0.01 and ***P<0.001.	
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Figure 23. MRI imaging of wild-type (left) and Cnot3ad-/- (right) mice after 12 weeks on 
HFD feeding. Cross-section at the level of the interscapular region (A), thorax (B) and 
abdomen (C). D, diaphragm; scWAT, subcutaneous WAT; mWAT, mesenteric WAT; 
pWAT, retroperitoneal fat; BAT , Interscapular BAT; SC, spinal cord;. K, kidney.	
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Figure 24. Increased energy expenditure in HFD-fed Cnot3ad-/- mice. (A and B) Oxygen 
consumption (VO2) over 24 hr (A) and average VO2 (B) in wild-type and Cnot3ad-/-  mice 
fed on HFD. (C and D) CO2 production (VCO2) over 24 hr (C) and average VCO2 (D) in 
wild-type and Cnot3ad-/-  mice fed on HFD. (E and F) Respiration exchange ratio (RER) 
over 24 hr (E) and average RER (F) in wild-type and Cnot3ad-/-  mice fed on HFD. The 
data were normalized to body weight. n = 4 per group. (C and D) respiratory exchange 
ratio (RER)	  . n = 4 per group. *p < 0.05, **p < 0.01 *** p < 0.001	
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Figure 25.(A) Average daily food intake normalized to body weight. Daily food intake per 
mouse was measured over 7 days. n=10 for each genotype. (B) Rectal temperature of 
Cnot3ad-/- mice and their wild-type littermates under HFD feeding. n=10 for each 
genotype 	
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Figure 26. The resistance to diet-induced obesity exhibited by HFD-fed Cnot3ad-/- mice 
did not prevent the severe insulin resistance. Glucose tolerance tests (GTTs) (A) and 
Insulin tolerance tests (ITTs) (B) in wild-type and Cnot3ad-/- mice fed on HFD. Blood 
glucose levels were measured at each indicated time point following intraperitoneal 
injection of 0.5 g glucose per kg body weight or 1.0 U insulin per kg body weight. n=8–
10 for each genotype. Results expressed as mean ± SEM, *p < 0.05, * * p < 0.01, * * * p 
< 0.001.	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Figure 27. HFD-fed Cnot3ad-/- mice were resistant to obesity but lipid accumulation levels 
in adipose tissues and liver were not improved. Histologic sections of WAT (A,B),  BAT 
(C,D), and liver (E,F), of wild type and Cnot3ad-/- mice after 12 weeks HFD feeding. Scale 
bar, 100μm. 	
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Figure 28. Model of possible involvement of CNOT3 in specific mRNA decay. In Cnot3-
deficient adipose tissue, degradation of mRNA related to lipodystrophy such as Srebp1 is not 
completely triggered, resulting in lipodystrophy and associated metabolic complications.	
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Table 2 List of primer sequences for qRT-PCR analysis 
Gene Forward primer Reverse primer 
Leptin TCAAGCAGTGCCTATCCAGA AAGCCCAGGAATGAAGTCCA  
Pparg1 TGAAAGAAGCGGTGAACCACTG TGGCATCTCTGTGTCAACCATG 
Pparg2 GTTTTATGCTGTTATGGGTG GTAATTTCTTGTGAAGTGCTCATAG 
Cebpa AAACAACGCAACGTGGAGA GCGGTCATTGTCACTGGTC 
Cebpb TGATGCAATCCGGATCAA CACGTGTGTTGCGTCAGTC 
Fabp4 GAAAACGAGATGGTGACAAGC GCCCTTTCATAAACTCTTGTGG 
Lpl GAAAGCCGGAGAGACTCAGA TGGCATTTCACAAACACTGC 
Fasn GGCTGAGGCCTTATGCTTCT CGATCTTCCAGGCTCTTCAG 
Adipoq GATGGCACTCCTGGAGAGAA CAGCTCCTGTCATTCCAACA 
Mcp1 TCCCAATGAGTAGGCTGGAG  AAGTGCTTGAGGTGGTTGTG 
PU.1 CGGATGTGCTTCCCTTATCAAAC  TGACTTTCTTCACCTCGCCTGTC  
F4/80 CTGTAACCGGATGGCAAACT CTGTACCCACATGGCTGATG 
Cidea AAACCATGACCGAAGTAGCC AGGCCAGTTGTGATGACTAAGAC 
Pgc1a GAAAGGGCCAAACAGAGAGA GTAAATCACACGGCGCTCTT 
UCP1 CTGCCAGGACAGTACCCAAG TCAGCTGTTCAAAGCACACA 
Prdm16 GACATTCCAATCCCACCAGA CACCTCTGTATCCGTCAGCA 
HoxC8 GTCTCCCAGCCTCATGTTTC TCTGATACCGGCTGTAAGTTTGT 
HoxC9 GCAGCAAGCACAAAGAGGAGAAG GCGTCTGGTACTTGGTGTAGGG 
DPT CTGCCGCTATAGCAAGAGGT TGGCTTGGGTACTCTGTTGTC 
Pref1 AGTACGAATGCTCCTGCACAC CTGGCCCTCATCATCCAC 
Srebp1 TGGAGACATCGCAAACAAG  GGTAGACAACAGCCGCATC 
36B4 ACTGGTCTAGGACCCGAGAAG TCCCACCTTGTCTCCAGTCT 
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Table 3. Common alterations in gene expression between Cnot3ad-/- mice, aP2- 
nSrebp1c mice (Sr) and Ppargldi/+ mice 
Gene Symbol Cnot3ad-/-  Sr Ppargldi/+ 
Atp6v0d2 33.08762 9.810689 9.586352 
Atp6v0d2 24.53461 15.216072 6.5242734 
Ubd 22.24502 18.176474 4.8160057 
Gpnmb 21.43772 10.154126 6.1500793 
Mmp12 20.477654 7.7889333 8.49861 
Rgs1 18.15279 9.656038 6.8217173 
Adam8 14.653106 3.293955 4.1736326 
BC090627///Chkb///Cpt1b 13.505972 2.8459737 4.778608 
Rnf128 12.480404 11.810144 4.8790584 
Ptx3 12.312386 2.6123056 4.572586 
Clec4d 11.105232 10.539208 5.4622436 
Myo1f 10.51756 5.8811235 9.545781 
Gas2l3 9.792868 3.3634965 5.0809913 
Slc15a3 9.634179 4.966626 6.6345215 
Nceh1 8.897664 5.2589817 4.1819267 
Glipr1 8.622081 4.387046 4.4066997 
Slc37a2 8.281363 8.818674 3.2722108 
Rnf128 8.186457 13.052683 5.5072045 
Hpgds 8.068502 5.2188573 5.353414 
Hephl1 8.053279 11.273928 3.112512 
LOC100038947///Sirpb1a///Sirpb1b 7.708848 6.73981 9.267849 
Il7r 7.395923 4.7066603 5.1543264 
Stap1 7.374021 3.4476826 4.9083214 
Saa3 7.1283875 3.304791 5.85182 
Egr2 6.880793 3.165907 4.2676663 
Gas2l3 6.878086 8.23601 5.721606 
Cd84 6.8606653 3.9313505 4.3929043 
Cd300lb 6.237835 2.9473276 3.7715843 
  6.2352467 2.6469953 4.82692 
 85 
Gp49a///Lilrb4 5.9790707 5.354253 4.2251782 
Syngr1 5.943864 3.2444184 2.8738883 
Tnfaip2 5.7677865 4.211666 2.648325 
Sel1l3 5.6567383 4.062649 2.6104815 
Sirpb1a 5.6034284 4.10811 4.569261 
Ms4a7 5.573173 6.3547072 8.929953 
Dhcr7 5.483312 9.554989 2.6028285 
Itgb2 5.3336196 3.707813 3.4741802 
AF251705 5.313738 4.7287655 4.860008 
  5.281763 4.800038 5.609574 
Atf3 5.249977 3.2650237 4.30438 
Tlr13 5.2391863 3.4600484 4.1681376 
Fcgr1 5.1961966 3.5480723 5.575852 
Myo1f 5.1530848 3.4528615 3.3839786 
Soat1 5.0243497 2.9990659 2.655846 
C3ar1 5.0050144 5.396723 4.38334 
Vsig4 4.9685345 4.946934 3.8997986 
Nceh1 4.952117 2.8143167 3.0553768 
Lipa 4.8687444 4.422588 3.1223793 
Lpxn 4.844463 3.3294284 4.3958635 
Sh3bgrl2 4.821051 8.904034 3.0627503 
Blnk 4.73978 2.598941 3.4694054 
Lcp1 4.719951 3.033085 3.9179642 
Hk3 4.474945 7.4301524 3.9512708 
Il1rn 4.385892 2.7079923 3.2642322 
Adssl1 4.3647285 3.6326184 4.2141976 
Gla 4.3517866 5.6278105 2.7533383 
Ms4a6d 4.296815 4.353101 7.5985646 
Plek 4.2887893 4.299423 4.367061 
Cxcl2 4.2763424 5.481742 4.005331 
Ccl8///LOC100503254 4.2554717 6.720313 8.293636 
Tyrobp 4.225148 2.8367 3.7948747 
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Mpeg1 4.2040443 5.36486 6.068006 
Runx2 4.183405 3.0392432 2.665151 
Cd44 3.9880695 2.5492945 4.0930285 
Arhgap25 3.9607818 2.7931817 3.4228747 
Soat1 3.9504743 4.71612 2.5526962 
Cadm1 3.8520896 2.522139 4.3380046 
Emr1 3.8295417 3.307787 3.1338458 
Bcl2a1a///Bcl2a1b///Bcl2a1d 3.819242 3.5564747 5.528718 
Clec4a2 3.8116543 2.930638 4.5165434 
Evi2a 3.7805014 2.701513 3.4836273 
Ctss 3.7668247 3.1078336 3.6910787 
Lipa 3.6363273 3.9490979 3.0024137 
Lgals3 3.610286 2.6200294 2.804145 
Plac8 3.5879545 4.244216 7.493948 
Ifi30 3.5301251 3.065401 4.1522775 
Fmn1 3.519733 4.305155 3.1109025 
Trav9d-3 3.5102053 2.7723846 4.3916216 
Mreg 3.4713526 4.8967347 3.4062834 
Tpd52 3.4615855 3.290438 3.2672234 
Tpd52 3.444644 2.6440835 2.9244926 
Apobec1 3.436342 4.5847936 3.875408 
Ms4a6d 3.4309351 4.732254 6.3539133 
Rasgef1b 3.4305656 2.798825 2.7915344 
Clec7a 3.4205937 3.569485 3.5505793 
Cd72 3.4196198 2.9965196 7.9505415 
Cdt1 3.404903 2.964215 2.8823097 
Plek 3.3843572 4.2045627 3.1005783 
Lair1 3.380313 3.0466354 6.4997187 
Soat1 3.3737845 3.2053733 2.8246162 
Hk3 3.307934 3.0944223 3.2940066 
Basp1 3.2674203 2.6278448 2.53381 
Ms4a4c 3.1970384 3.6948576 8.713206 
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Galnt6 3.191125 3.130455 2.7094235 
Tlr1 3.1484253 4.228831 4.6859097 
Capn9 3.1380696 2.9420402 3.3880258 
  3.1214275 3.3966806 4.4317026 
Evl 3.1099327 3.277143 3.0488527 
Naip2 3.0912554 5.093412 4.155447 
Cd48 3.0730634 2.8741891 3.4370227 
Cd53 3.0332565 2.689707 3.3658493 
Casp1 3.0104728 4.8834686 4.9914384 
Gm11428///LOC100504934 2.9978454 2.941623 3.161411 
Nckap1l 2.7658994 2.503009 2.9571748 
Fyb 2.6945875 3.6301687 4.3732305 
Fcgr4 2.6935823 7.2860966 6.34155 
Chchd10 2.6695423 3.569411 3.5217676 
Oasl1 2.6294043 7.7111597 2.8229966 
Msr1 2.616367 2.668048 5.051168 
Gpr65 2.5295546 3.2761838 5.5563107 
 
